Spots Global Cancer Trial Database for multiple endocrine neoplasia
Every month we try and update this database with for multiple endocrine neoplasia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study and Follow-up of Multiple Endocrine Neoplasia Type 1 | NCT03348501 | Multiple Endocr... | survey for long... | - | Centre Hospitalier Universitaire Dijon | |
| A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors | NCT00947167 | Neuroendocrine ... Carcinoid Tumor... Adrenal Gland T... Neuroblastoma Pancreatic Neur... Multiple Endocr... | pertuzumab erlotinib | - | Stanford University | |
| A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors | NCT00947167 | Neuroendocrine ... Carcinoid Tumor... Adrenal Gland T... Neuroblastoma Pancreatic Neur... Multiple Endocr... | pertuzumab erlotinib | - | Stanford University | |
| Variables That Are Correlated to Developing Multiple Endocrine Neoplasia (MEN) and Pancreatic Neuroendocrine Tumors (PNET) | NCT03053999 | Multiple Endocr... Pancreatic Neur... Hyperparathyroi... | Genome Sequenci... Data Review | - | M.D. Anderson Cancer Center | |
| Studies of Elevated Parathyroid Activity | NCT00001277 | Hyperparathyroi... Hypercalcemia Parathyroid Neo... Multiple Endocr... MEN1 | 68Ga-Dotatate 18F-DOPA | 2 Months - | National Institutes of Health Clinical Center (CC) | |
| Cinacalcet to Treat Familial Primary Hyperparathyroidism | NCT00325104 | Hypercalcemia Familial Primar... | Parathyroid hor... Serum calcium t... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Cinacalcet to Treat Familial Primary Hyperparathyroidism | NCT00325104 | Hypercalcemia Familial Primar... | Parathyroid hor... Serum calcium t... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Metabolomics and Genetic Diagnosing Pancreatic Neuroendocrine Tumors in MEN1 Patients | NCT03048266 | Multiple Endocr... | - | M.D. Anderson Cancer Center | ||
| Psychosocial Aspects of Multiple Endocrine Neoplasia (MEN) Syndromes | NCT00501449 | Multiple Endocr... | Questionnaire | 18 Years - | M.D. Anderson Cancer Center | |
| Study and Follow-up of Multiple Endocrine Neoplasia Type 1 | NCT03348501 | Multiple Endocr... | survey for long... | - | Centre Hospitalier Universitaire Dijon | |
| Study and Follow-up of Multiple Endocrine Neoplasia Type 1 | NCT03348501 | Multiple Endocr... | survey for long... | - | Centre Hospitalier Universitaire Dijon | |
| A Retrospective Study for Multiple Endocrine Neoplasia | NCT05812573 | Multiple Endocr... | no intervention | 18 Years - 99 Years | National Taiwan University Hospital | |
| Studies of Inherited Diseases of Metabolism | NCT00001345 | Multiple Endocr... | 4 Years - | National Institutes of Health Clinical Center (CC) | ||
| A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors | NCT00947167 | Neuroendocrine ... Carcinoid Tumor... Adrenal Gland T... Neuroblastoma Pancreatic Neur... Multiple Endocr... | pertuzumab erlotinib | - | Stanford University | |
| Psychosocial Aspects of Multiple Endocrine Neoplasia (MEN) Syndromes | NCT00501449 | Multiple Endocr... | Questionnaire | 18 Years - | M.D. Anderson Cancer Center | |
| Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer | NCT00514046 | Medullary Thyro... Multiple Endocr... Multiple Endocr... | Vandetanib | 5 Years - 18 Years | National Institutes of Health Clinical Center (CC) | |
| Treatment of Zollinger-Ellison Syndrome With Prevacid | NCT00204373 | Zollinger-Ellis... Multiple Endocr... | Lansoprazole (P... | 19 Years - | University of Alabama at Birmingham |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
